This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
"What's Sex and Gender Got to Do With It?" A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence.
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research · 2023
The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.
PloS one · 2013
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
Annals of neurology · 2011
Latest funding
- $4,000
Could Anticholinergics Accelerate Amyotrophic Lateral Sclerosis (ALS) Progression? Integrating Mechanistic Insights and Real-World Evidence to Advance Drug Safety in ALS
CIHR · 2025 · Supervisor
- $4,000
Fingolimod and Risk of Skin Cancer Among Individuals with Multiple Sclerosis: A Population-Based Cohort Study
CIHR · 2025 · Supervisor
- $6,000
Impact of socioeconomic factors on treatment outcomes for patients with multiple sclerosis
CIHR · 2024 · Supervisor
3 publications.
"What's Sex and Gender Got to Do With It?" A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence.
Rebić N, Law MR, Cragg J, Brotto LA, Ellis U, Garg R, Park JY, De Vera MA
The nature of progression in Parkinson's disease: an application of non-linear, multivariate, longitudinal random effects modelling.
Kuramoto L, Cragg J, Nandhagopal R, Mak E, Sossi V, de la Fuente-Fernández R, Stoessl AJ, Schulzer M
Age-specific progression of nigrostriatal dysfunction in Parkinson's disease.
de la Fuente-Fernández R, Schulzer M, Kuramoto L, Cragg J, Ramachandiran N, Au WL, Mak E, McKenzie J, McCormick S, Sossi V, Ruth TJ, Lee CS, Calne DB, Stoessl AJ
Could Anticholinergics Accelerate Amyotrophic Lateral Sclerosis (ALS) Progression? Integrating Mechanistic Insights and Real-World Evidence to Advance Drug Safety in ALS
Principal investigators: Price, Tiffany R
Keywords: Amyotrophic Lateral Sclerosis; Anticholinergic Burden; Clinical Registry; Disease Progression; Drug Safety; Health Policy; Ics Travel Awards; Pharmacoepidemiology; Population Health Data; Survival
Fingolimod and Risk of Skin Cancer Among Individuals with Multiple Sclerosis: A Population-Based Cohort Study
Principal investigators: Jia, Beiqi
Keywords: Administrative Data; Disease Modifying Therapies; Drug Safety; Ics Travel Awards; Multiple Sclerosis; Pharmacoepidemiology; Real-World Evidence; Skin Cancer
Impact of socioeconomic factors on treatment outcomes for patients with multiple sclerosis
Principal investigators: Jia, Beiqi
Keywords: Cohort Analysis; Inequity; Multiple Sclerosis; Neurological Outcomes; Policy; Public Health; Socioeconomic Factors
Canada Research Chair - Tier 2
Principal investigators: Cragg, Jacquelyn J
Keywords: Crc
Anticholinergic effects on progression in amyotrophic lateral sclerosis: a retrospective cohort study
Principal investigators: Price, Tiffany R
Keywords: Amyotrophic Lateral Sclerosis; Anticholinergics; Canadian Population Health Data; Clinical Registry; Cohort Study; Disease Progression; Pharmacoepidemiology; Survival
Establishing best practices to support open science in traumatic spinal cord injury research
Principal investigators: Cragg, Jacquelyn J
Keywords: Open Data Science; Open Science; Spinal Cord Injury
Ethical partnerships with transGender And Gender diverse communities for conducting pharmacoEpidemiologic research (EnGAGE)
Principal investigators: Rebic, Nevena
Keywords: Administrative Health Data; Medication Adherence; Participatory Research Design; Patient-Oriented Research; Pharmacoepidemiology; Population-Based Studies; Sex And Gender Analysis; Transgender Health Research
Spinal Cord Injury Pharmacovigilance in Canada: Using Electronic Health Data to Examine Medication Use, Adherence, and Safety
Principal investigators: Jia, Beiqi
Keywords: Cost-Saving Analysis; Drug Adherence; Drug Safety; Machine-Learning Algorithms; Model-Building; Pharmacoepidemiology; Pharmacological Treatment; Polypharmacy; Spinal Cord Injury; Statistical Analysis
Predictive modeling in multiple sclerosis: using real world data to inform practice, policy, and research
Principal investigators: Cragg, Jacquelyn J; Lynd, Larry D
Keywords: Data Linkage; Disease Progression; Multiple Sclerosis; Predictive Disease Modeling
In the shadows of the opioid crisis: the epidemiology and impact of methamphetamine use in Canada
Principal investigators: Cragg, Jacquelyn J; Lysyshyn, Mark; Bach, Paxton J
Keywords: Administrative Data; Demographic Trends; Epidemiology; Geographic Trends; Hospitalizations; Methamphetamine; Temporal Trends
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.